BABA
Alibaba Group Holding Limited
BABA's outlook is improving, though it still trails on the overall score.
SN
SharkNinja, Inc.
SN has the edge over BABA overall, supported by stronger fundamentals and stronger modeled upside.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
SN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
SN's revenue, profitability, cash flow and balance sheet are all currently healthy.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
SN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 26x | $155 | -29% |
| Forward | 30x | $220 | — |
| Fair | 36x | $214 | -2.8% |
| Current | 37x | $220 | — |
| Expensive | 55x | $329 | +50% |
Historical ranges are pointers, not guarantees.
SN has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
SN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for SN, with profitability improving. However, they disagree widely on these estimates.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
SN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.26 | +22% |
| Q3 2026 | $5.96 | +47% |
| Q2 2026 | $4.90 | +34% |
| Q1 2026 | $4.96 | +57% |
| Q4 2025 | $4.94 | +59% |
| Q3 2025 | $4.05 | +59% |
| Q2 2025 | $3.66 | +110% |
| Q1 2025 | $3.16 | +134% |
| Q4 2024 | $3.11 | +159% |
SN has the edge over BABA on earnings, with more consistent year-over-year improvement.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
SN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +21% |
| Q2 2026 | $1.8B | +22% |
| Q1 2026 | $1.4B | +16% |
| Q4 2025 | $2.1B | +18% |
| Q3 2025 | $1.6B | +14% |
| Q2 2025 | $1.4B | +16% |
| Q1 2025 | $1.2B | +15% |
| Q4 2024 | $1.8B | +30% |
SN has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +5.9 points |
| Q2 2026 | 10% | -1.5 points |
| Q1 2026 | 12% | -0.2 points |
| Q4 2025 | 16% | +4.9 points |
| Q3 2025 | 17% | +3.9 points |
| Q2 2025 | 12% | +3.3 points |
| Q1 2025 | 12% | -2.8 points |
| Q4 2024 | 11% | +4.2 points |
SN has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
SN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$209.7M | -343% |
| Q2 2026 | $382.6M | +$419.2M |
| Q1 2026 | -$190.2M | -$98.5M |
| Q4 2025 | $523.3M | +19% |
| Q3 2025 | $86.2M | +$151.2M |
| Q2 2025 | -$36.5M | +$57.5M |
| Q1 2025 | -$91.7M | -639% |
| Q4 2024 | $441.4M | +237% |
SN has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
SN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +14.5K shares |
| 1 year | -0.4% | -598K shares |
| 3 years | +1.5% | +2.1M shares |
SN has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50.5M |
| Q2 2026 | $100.7M |
| Q1 2026 | $18.5M |
| Q4 2025 | — |
| Q3 2025 | $1.1M |
| Q2 2025 | $788,000 |
| Q1 2025 | $48.4M |
| Q4 2024 | $11.4M |
SN spent $170M buying back its own shares over the past year, up 175% from the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
SN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 0.8x | Very low |
SN has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
SN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.4 | Overbought |
| Stochastic | 91.2 | Overbought |
SN's weekly RSI is 74 (overbought) and its Stochastic is 91 (overbought).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over SN on valuation relative to its sector.
SN PE vs Consumer Cyclical Sector
| Metric | SN | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 18x | 105% above |
| PE % | 52 | 33 | 19 pts above |
SN is trading at 37x earnings, a 105% premium to the Consumer Cyclical sector's median of 18x.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
SN has stronger trend alignment. BABA is above 0 of 5 weekly averages versus SN above 4 of 4.
SN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $197.4 | 12% above |
| 20 week MA | $179.5 | 23% above |
| 50 week MA | $142.3 | 55% above |
| 100 week MA | $120.7 | 82% above |
SN is in an uptrend: it's above all four of its weekly moving averages, and 82% above its 100-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
SN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $26.9 | $51.2 | +90% |
| 2024 | $51.2 | $97.3 | +90% |
| 2025 | $97.3 | $114.0 | +17% |
| 2026 YTD | $114.0 | $220.1 | +93% |
SN has the edge over BABA on returns for 2026, with the stronger performance.